Literature DB >> 15723409

129Xe spectra from the heads of rats with and without ligation of the external carotid and pterygopalatine arteries.

Kazuhiro Nakamura1, Yasushi Kondoh, Atsushi Wakai, Jeff Kershaw, David Wright, Iwao Kanno.   

Abstract

After rats inhaled hyperpolarized (129)Xe gas, in vivo spectra from their heads revealed a dominant peak around 195 ppm, another easily resolvable peak near 189 ppm, a broad peak around 210 ppm, and two minor peaks around 198 ppm and 192 ppm. However, the source of each peak remains controversial. To further study the origin of each peak, we compared spectra obtained from the heads of normal rats with spectra taken from the heads of rats that had undergone ligation of the external carotid (ECA) and pterygopalatine (PPA) arteries, the major feeding vessels of nonbrain tissue in the rat head. The amplitude of the peak at around 189 ppm was greatly reduced in the ECA/PPA-ligated rats, while the peak around 195 ppm persisted. We conclude that the signal that originates from the rat brain after inhalation of (129)Xe gas is overwhelmingly dominated by the single resonance at 195 ppm. (c) 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15723409     DOI: 10.1002/mrm.20399

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  9 in total

1.  Rapid assessment of pulmonary gas transport with hyperpolarized 129Xe MRI using a 3D radial double golden-means acquisition with variable flip angles.

Authors:  Kai Ruppert; Faraz Amzajerdian; Hooman Hamedani; Yi Xin; Luis Loza; Tahmina Achekzai; Ian F Duncan; Harrilla Profka; Sarmad Siddiqui; Mehrdad Pourfathi; Maurizio F Cereda; Stephen Kadlecek; Rahim R Rizi
Journal:  Magn Reson Med       Date:  2018-04-22       Impact factor: 4.668

2.  Simple and robust referencing system enables identification of dissolved-phase xenon spectral frequencies.

Authors:  Michael A Antonacci; Le Zhang; Alex Burant; Drew McCallister; Rosa T Branca
Journal:  Magn Reson Med       Date:  2017-12-19       Impact factor: 4.668

3.  Continuously infusing hyperpolarized 129Xe into flowing aqueous solutions using hydrophobic gas exchange membranes.

Authors:  Zackary I Cleveland; Harald E Möller; Laurence W Hedlund; Bastiaan Driehuys
Journal:  J Phys Chem B       Date:  2009-09-17       Impact factor: 2.991

Review 4.  Perspectives of hyperpolarized noble gas MRI beyond 3He.

Authors:  David M L Lilburn; Galina E Pavlovskaya; Thomas Meersmann
Journal:  J Magn Reson       Date:  2012-12-08       Impact factor: 2.229

5.  Distribution of hyperpolarized xenon in the brain following sensory stimulation: preliminary MRI findings.

Authors:  Mary L Mazzanti; Ronn P Walvick; Xin Zhou; Yanping Sun; Niral Shah; Joey Mansour; Jessica Gereige; Mitchell S Albert
Journal:  PLoS One       Date:  2011-07-15       Impact factor: 3.240

6.  High resolution spectroscopy and chemical shift imaging of hyperpolarized (129) Xe dissolved in the human brain in vivo at 1.5 tesla.

Authors:  Madhwesha Rao; Neil J Stewart; Graham Norquay; Paul D Griffiths; Jim M Wild
Journal:  Magn Reson Med       Date:  2016-04-15       Impact factor: 4.668

7.  Dissolved hyperpolarized xenon-129 MRI in human kidneys.

Authors:  Jorge Chacon-Caldera; Adam Maunder; Madhwesha Rao; Graham Norquay; Oliver I Rodgers; Matthew Clemence; Claudio Puddu; Lothar R Schad; Jim M Wild
Journal:  Magn Reson Med       Date:  2019-08-09       Impact factor: 4.668

Review 8.  Hyperpolarized 129 Xe imaging of the brain: Achievements and future challenges.

Authors:  Yurii Shepelytskyi; Vira Grynko; Madhwesha R Rao; Tao Li; Martina Agostino; Jim M Wild; Mitchell S Albert
Journal:  Magn Reson Med       Date:  2022-03-07       Impact factor: 3.737

9.  129 Xe chemical shift in human blood and pulmonary blood oxygenation measurement in humans using hyperpolarized 129 Xe NMR.

Authors:  Graham Norquay; General Leung; Neil J Stewart; Jan Wolber; Jim M Wild
Journal:  Magn Reson Med       Date:  2016-04-08       Impact factor: 4.668

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.